| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Mineralys Therapeutics, Inc. (MLYS) has 8 insiders with recent SEC Form 4 filings, including 9 buys and 3 sells. MLYS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 7.90M | $233.48M | - | |
| Dir | 5.46M | $161.19M | - | |
| CEO | 689.3K | $20.36M | -15,730 | |
| Dir | 588.2K | $17.38M | - | |
| Other | 69.8K | $2.06M | -20,822 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12, 2024 | Samsara Biocapital Gp, LLC59 | 10% Owner | Buy | 555,555 | $13.50 | $7,499,992.50 | +12.3% | -12.2% | -34.4% | |
| Nov 22, 2023 | Congleton Jon47 | Chief Executive Officer | Buy | 4,250 | $5.97 | $25,355.93 | +0.4% | +156.7% | +99.2% | |
| Sep 6, 2023 | Congleton Jon47 | Chief Executive Officer | Buy | 2,250 | $12.08 | $27,180.00 | +0.2% | -43.9% | -1.5% | |
| Aug 17, 2023 | Congleton Jon47 | Chief Executive Officer | Buy | 2,250 | $12.10 | $27,225.00 | +0.2% | -44.3% | -19.5% | |
| Aug 11, 2023 | Congleton Jon47 | Chief Executive Officer | Buy | 2,000 | $12.89 | $25,780.00 | +0.2% | -42.2% | -14.0% | |
| Aug 11, 2023 | Rodman David Malcom58 | Chief Medical Officer | Sale+OE | 231,716 | $12.92 | $2,994,400.71 | -100% | -42.2% | -14.0% | |
| Feb 14, 2023 | Akkaraju Srinivas81 | Director, 10% Owner | Buy | 937,500 | $16.00 | $15,000,000.00 | +26.2% | -10.1% | -19.3% | |
| Feb 14, 2023 | Levy Adam Scott | CFO, Chief Bus. Off. And Secy. | Buy | 6,250 | $16.00 | $100,000.00 | +1.8% | -10.1% | -19.3% | |
| Feb 14, 2023 | Hbm Healthcare Investments (cayman) Ltd. | 10% Owner | Buy | 312,500 | $16.00 | $5,000,000.00 | +10.8% | -10.1% | -19.3% | |
| Feb 14, 2023 | Slingsby Brian Taylor48 | Director, 10% Owner | Buy | 250,000 | $16.00 | $4,000,000.00 | +2.8% | -10.1% | -19.3% |